Literature DB >> 2757923

In vitro antagonism between cisplatin and vinca alkaloids.

K Lee1, M Tanaka, H Kanamaru, T Hashimura, I Yamamoto, J Konishi, F Kuze.   

Abstract

The effects of the combination of cisplatin and other cytotoxic agents were studied in vitro. When A549 lung cancer cells were treated simultaneously with cisplatin and other cytotoxic agents, cisplatin additively increased the cytotoxic effects of etoposide, mitomycin C, adriamycin, 5-fluorouracil and 1-beta-D-arabinofuranosylcytosine, but antagonised those of vincristine, vindesine, vinblastine and podophyllotoxin. The antagonism between cisplatin and vincristine was also observed with HT29 colon cancer cells. NC65 renal carcinoma cells and A431 epidermoid carcinoma cells when these cells were simultaneously exposed to both agents. When A549 cells were exposed to cisplatin and vincristine sequentially, the antagonism between them was evident when cells were pretreated with cisplatin but not when treated in the opposite sequence. Therefore, when combination chemotherapy including cisplatin and vinca alkaloids is given, possible antagonism between them should be considered, especially in determining the schedule of drug administration.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2757923      PMCID: PMC2246974          DOI: 10.1038/bjc.1989.8

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  15 in total

1.  Effects of podophyllotoxin and VP-16-213 on microtubule assembly in vitro and nucleoside transport in HeLa cells.

Authors:  J D Loike; S B Horwitz
Journal:  Biochemistry       Date:  1976-12-14       Impact factor: 3.162

2.  Interaction of drugs with microtubule proteins.

Authors:  L Wilson; J R Bamburg; S B Mizel; L M Grisham; K M Creswell
Journal:  Fed Proc       Date:  1974-02

3.  Peripheral neuropathy after cis-platinum (II) (DDP) therapy.

Authors:  L Reinstein; S S Ostrow; P H Wiernik
Journal:  Arch Phys Med Rehabil       Date:  1980-06       Impact factor: 3.966

4.  Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on microtubules in vitro.

Authors:  R H Himes; R N Kersey; I Heller-Bettinger; F E Samson
Journal:  Cancer Res       Date:  1976-10       Impact factor: 12.701

5.  Nerve conduction studies in patients treated with cis-diamminedichloroplatinum(II): a preliminary report.

Authors:  J D Cowan; M S Kies; J L Roth; R P Joyce
Journal:  Cancer Treat Rep       Date:  1980 Oct-Nov

6.  Adjuvant chemotherapy in the treatment of advanced tumors of the head and neck.

Authors:  M B Spaulding; D Klotch; J Grillo; S Sanani; J M Loré
Journal:  Am J Surg       Date:  1980-10       Impact factor: 2.565

7.  Renal cell carcinoma: two new cell lines and a serially transplantable nude mouse tumor (NC 65). Preliminary report.

Authors:  W Höehn; F H Schroeder
Journal:  Invest Urol       Date:  1978-09

8.  Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer.

Authors:  L H Einhorn; J Donohue
Journal:  Ann Intern Med       Date:  1977-09       Impact factor: 25.391

9.  Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules.

Authors:  R J Gralla; E S Casper; D P Kelsen; D W Braun; M E Dukeman; N Martini; C W Young; R B Golbey
Journal:  Ann Intern Med       Date:  1981-10       Impact factor: 25.391

10.  Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.

Authors:  B J Sugarman; B B Aggarwal; P E Hass; I S Figari; M A Palladino; H M Shepard
Journal:  Science       Date:  1985-11-22       Impact factor: 47.728

View more
  3 in total

1.  Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotubule agents taxol and vincristine.

Authors:  E K Rowinsky; M J Citardi; D A Noe; R C Donehower
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

2.  The prognosis of breast cancer patients in relation to the oestrogen receptor status of both primary disease and involved nodes.

Authors:  L Castagnetta; A Traina; G Carruba; E Fecarotta; G Palazzotto; R Leake
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

3.  Kinetic analysis of combination effect of navelbine (KW-2307) with cisplatin against human lung adenocarcinoma PC-12 cells in culture.

Authors:  K Gomi; H Ohno; K Nomura; M Okabe; K Kobayashi; H Niitani
Journal:  Jpn J Cancer Res       Date:  1992-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.